Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Change in Account Payables (2017 - 2018)

InflaRx's Change in Account Payables history spans 2 years, with the latest figure at $2.9 million for Q4 2018.

  • On a quarterly basis, Change in Account Payables fell 31.17% to $2.9 million in Q4 2018 year-over-year; TTM through Dec 2018 was $2.4 million, a 31.58% decrease, with the full-year FY2025 number at -$7.0 million, down 1025.67% from a year prior.
  • Change in Account Payables hit $2.9 million in Q4 2018 for InflaRx, up from $2.5 million in the prior quarter.
  • Over the last five years, Change in Account Payables for IFRX hit a ceiling of $4.2 million in Q4 2017 and a floor of -$1.9 million in Q1 2018.